These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 7891351)
21. Properties of delta opioid receptor in neuroblastoma NS20Y: receptor activation and neuroblastoma proliferation. Law PY; Bergsbaken C J Pharmacol Exp Ther; 1995 Jan; 272(1):322-32. PubMed ID: 7815347 [TBL] [Abstract][Full Text] [Related]
22. The cloned kappa opioid receptor couples to an N-type calcium current in undifferentiated PC-12 cells. Tallent M; Dichter MA; Bell GI; Reisine T Neuroscience; 1994 Dec; 63(4):1033-40. PubMed ID: 7700508 [TBL] [Abstract][Full Text] [Related]
23. Differential effects of agonists on adenylyl cyclase superactivation mediated by the kappa opioid receptors: adenylyl cyclase superactivation is independent of agonist-induced phosphorylation, desensitization, internalization, and down-regulation. Wang Y; Li JG; Huang P; Xu W; Liu-Chen LY J Pharmacol Exp Ther; 2003 Dec; 307(3):1127-34. PubMed ID: 14557376 [TBL] [Abstract][Full Text] [Related]
24. Differential antagonism of U69,593- and bremazocine-induced antinociception by (-)-UPHIT: evidence of kappa opioid receptor multiplicity in mice. Horan P; de Costa BR; Rice KC; Porreca F J Pharmacol Exp Ther; 1991 Jun; 257(3):1154-61. PubMed ID: 1646325 [TBL] [Abstract][Full Text] [Related]
25. Opioid receptors are coupled tightly to G proteins but loosely to adenylate cyclase in NG108-15 cell membranes. Costa T; Klinz FJ; Vachon L; Herz A Mol Pharmacol; 1988 Dec; 34(6):744-54. PubMed ID: 2849042 [TBL] [Abstract][Full Text] [Related]
26. Agonist-induced desensitization and down-regulation of the human kappa opioid receptor expressed in Chinese hamster ovary cells. Zhu J; Luo LY; Mao GF; Ashby B; Liu-Chen LY J Pharmacol Exp Ther; 1998 Apr; 285(1):28-36. PubMed ID: 9535991 [TBL] [Abstract][Full Text] [Related]
27. kappa-opioid receptor expression defines a phenotypically distinct subpopulation of astroglia: relationship to Ca2+ mobilization, development, and the antiproliferative effect of opioids. Gurwell JA; Duncan MJ; Maderspach K; Stiene-Martin A; Elde RP; Hauser KF Brain Res; 1996 Oct; 737(1-2):175-87. PubMed ID: 8930364 [TBL] [Abstract][Full Text] [Related]
28. Kappa opioid receptor tolerance in the guinea pig hippocampus. Jin W; Terman GW; Chavkin C J Pharmacol Exp Ther; 1997 Apr; 281(1):123-8. PubMed ID: 9103488 [TBL] [Abstract][Full Text] [Related]
29. The synthetic kappa-opioid agonist (-)U50,488 does not affect calcium transport into R1.1 mouse thymoma cell line. Martin-Kleiner I; Bidlack JM Int J Immunopharmacol; 1999 Feb; 21(2):133-40. PubMed ID: 10230876 [TBL] [Abstract][Full Text] [Related]
30. Modulation of adenylate cyclase activity of mouse spinal cord-ganglion explants by opioids, serotonin and pertussis toxin. Makman MH; Dvorkin B; Crain SM Brain Res; 1988 Apr; 445(2):303-13. PubMed ID: 3370465 [TBL] [Abstract][Full Text] [Related]
31. Opioid efficacy in a C6 glioma cell line stably expressing the human kappa opioid receptor. Remmers AE; Clark MJ; Mansour A; Akil H; Woods JH; Medzihradsky F J Pharmacol Exp Ther; 1999 Feb; 288(2):827-33. PubMed ID: 9918595 [TBL] [Abstract][Full Text] [Related]
32. Differential regulation of adenylyl cyclase activity by mu and delta opioids in rat caudate putamen and nucleus accumbens. Izenwasser S; Búzás B; Cox BM J Pharmacol Exp Ther; 1993 Oct; 267(1):145-52. PubMed ID: 7901389 [TBL] [Abstract][Full Text] [Related]
33. kappa-Opioid receptor activates an inwardly rectifying K+ channel by a G protein-linked mechanism: coexpression in Xenopus oocytes. Ma GH; Miller RJ; Kuznetsov A; Philipson LH Mol Pharmacol; 1995 May; 47(5):1035-40. PubMed ID: 7746270 [TBL] [Abstract][Full Text] [Related]
34. Differential antagonism of bremazocine- and U69,593-induced antinociception by quadazocine: further functional evidence of opioid kappa receptor multiplicity in the mouse. Horan PJ; de Costa BR; Rice K; Haaseth RC; Hruby VJ; Porreca F J Pharmacol Exp Ther; 1993 Aug; 266(2):926-33. PubMed ID: 8394923 [TBL] [Abstract][Full Text] [Related]
35. Inhibition of L-type calcium currents in guinea pig ventricular myocytes by the kappa-opioid agonist U50488H does not involve binding to opiate receptors. Utz J; Eckert R; Trautwein W J Pharmacol Exp Ther; 1995 Aug; 274(2):627-33. PubMed ID: 7543570 [TBL] [Abstract][Full Text] [Related]
36. Differential antagonism of the rate-decreasing effects of kappa-opioid receptor agonists by naltrexone and norbinaltorphimine. Powell KR; Holtzman SG Eur J Pharmacol; 1999 Jul; 377(1):21-8. PubMed ID: 10448921 [TBL] [Abstract][Full Text] [Related]
37. Mu type opioid receptors in rat periaqueductal gray-enriched P2 membrane are coupled to G-protein-mediated inhibition of adenylyl cyclase. Fedynyshyn JP; Lee NM FEBS Lett; 1989 Aug; 253(1-2):23-7. PubMed ID: 2547657 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of interleukin-1 and tumor necrosis factor-alpha synthesis following treatment of macrophages with the kappa opioid agonist U50, 488H. Belkowski SM; Alicea C; Eisenstein TK; Adler MW; Rogers TJ J Pharmacol Exp Ther; 1995 Jun; 273(3):1491-6. PubMed ID: 7791124 [TBL] [Abstract][Full Text] [Related]
39. Kappa-opioid agonists do not inhibit adenylate cyclase. Makimura M; Murakoshi Y J Pharmacobiodyn; 1989 Mar; 12(3):125-31. PubMed ID: 2547926 [TBL] [Abstract][Full Text] [Related]
40. Kappa opiate receptor multiplicity: evidence for two U50,488-sensitive kappa 1 subtypes and a novel kappa 3 subtype. Clark JA; Liu L; Price M; Hersh B; Edelson M; Pasternak GW J Pharmacol Exp Ther; 1989 Nov; 251(2):461-8. PubMed ID: 2553920 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]